Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.15
-0.12 (-1.06%)
At close: Sep 17, 2025, 4:00 PM EDT
11.60
+0.45 (4.04%)
Pre-market: Sep 18, 2025, 9:10 AM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $151.98 million as of September 18, 2025. Its market cap has decreased by -17.53% in one year.
Market Cap
151.98M
Enterprise Value
148.85M
1-Year Change
-17.53%
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $151.98M, an increase of 121.26%. That is a compound annual growth rate of 17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 151.98M | 2.96% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | 68.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |